Schwab Andrew J.
Schwab Andrew J., DIR, reported an open-market or private sale at Camp4 Therapeutics Corp involving 400000.000000 shares for an estimated $1616000.00. Reported holdings after the transaction were 2033270.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 27, 2026
- Filing date
- Aug 31, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 2,433,270 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CAMP price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001598549-26-000011 Common Stock
- Transaction date
- Aug 27, 2026 Filed Aug 31, 2026, 09:05 PM · 4d delay
- Shares
- 400,000 sh $4.04 per share
- Estimated value
- -$1.61M Computed from shares × price
- Holdings after
- 2,033,270 sh Indirect · By 5AM Ventures VI, L.P.
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1F2F3(3 footnotes)
The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. The Reporting Person is a managing member of Par…
0 other transactions
0 recent txs